cbdMD (YCBD) Liabilities and Shareholders Equity (2016 - 2025)

cbdMD has disclosed Liabilities and Shareholders Equity across 10 years of filings, most recently posting $11.8 million for Q4 2025.

• Liabilities and Shareholders Equity for Q4 2025 came in at $11.8 million, up 2.07% year-over-year; the trailing twelve-month figure through Dec 2025 was $43.0 million (down 14.81% YoY), and the FY2025 annual result was $10.4 million, down 1.53% from the prior year.
• Liabilities and Shareholders Equity came in at $11.8 million for Q4 2025 at cbdMD, up from $10.4 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $124.9 million in Q3 2021 to a low of $9.9 million in Q2 2025.
• The 5-year median for Liabilities and Shareholders Equity is $24.6 million (2023), against an average of $43.9 million.
• Across the five-year window, Liabilities and Shareholders Equity rose 12.67% in 2021 and slumped 67.34% in 2022, its largest moves.
• cbdMD's Liabilities and Shareholders Equity stood at $99.3 million in 2021, then sank by 64.03% to $35.7 million in 2022, then plunged by 57.75% to $15.1 million in 2023, then slipped by 23.53% to $11.5 million in 2024, then grew by 2.07% to $11.8 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $11.8 million (Q4 2025), $10.4 million (Q3 2025), and $9.9 million (Q2 2025), per Business Quant data.